Bone marrow mesenchymal stem cell-derived exosomes promote tendon regeneration by facilitating the proliferation and migration of endogenous tendon stem/progenitor cells
Source abstract
Abstract
Mesenchymal stem cells (MSCs)-derived exosomes are being increasingly focused as the new biological pro-regenerative therapeutic agents for various types of tissue injury. Here, we explored the potential of a novel exosome-based therapeutic application combined with a local fibrin delivery strategy for tendon repair. After discovering that bone marrow mesenchymal stem cells-derived exosomes (BMSCs-exos) promoted the proliferation, migration and tenogenic differentiation of tendon stem/progenitor cells (TSPCs) in vitro, we embedded BMSCs-exos in fibrin and injected it into the defect area of rat patellar tendon, and the results showed that the exosomes could be controlled-released from the fibrin, retained within the defect area, and internalized by TSPCs. BMSCs-exos embedded in fibrin significantly improved the histological scores, enhanced the expression of mohawk, tenomodulin, and type I collagen, as well as the mechanical properties of neotendon, and also promoted the proliferation of local TSPCs in vivo. Overall, we demonstrated the beneficial role of BMSCs-exos in tendon regeneration, and that fibrin-exosomes delivery system represents a successful local treatment strategy of exosomes. This study brings prospects in the potential application of exosomes in novel therapies for tendon injury. STATEMENT OF SIGNIFICANCE: Mesenchymal stem cells have been identified as a preferred approach in tissue regeneration. In this study, we reported bone marrow mesenchymal stem cells (BMSCs) promote the proliferation and migration of tendon stem/progenitor cells (TSPCs) via the paracrine signaling effect of the nanoscale exosomes. We also demonstrated that the application of BMSCs-derived exosomes might be a promising approach to activate the regenerative potential of endogenous TSPCs in tendon injured region, and fibrin-exosomes delivery system represents a successful local treatment strategy of exosomes.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tendon Structure and Treatment · Sports injuries and prevention · Musculoskeletal synovial abnormalities and treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Progress in cell-based therapies for tendon repair10.1016/j.addr.2014.11.023 ↗
2. The past, present and future in scaffold-based tendon treatments10.1016/j.addr.2014.11.022 ↗
3. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model10.1111/j.1440-1797.2012.01589.x ↗
4. Renal regenerative potential of different extracellular vesicle populations derived from bone marrow mesenchymal stromal cells10.1089/ten.tea.2017.0069 ↗
5. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine10.1186/s13287-018-0791-7 ↗
6. Concise review: MSC-derived exosomes for cell-free therapy10.1002/stem.2575 ↗
7. Tenocyte proliferation and migration promoted by rat bone marrow mesenchymal stem cell-derived conditioned medium10.1007/s10529-017-2446-7 ↗
8. Mesenchymal stem cell secretome improves tendon cell viability in vitro and tendon-bone healing in vivo when a tissue engineering strategy is used in a rat model of chronic massive rotator cuff tear10.1177/0363546517735850 ↗
9. Stepwise differentiation of mesenchymal stem cells augments tendon-like tissue formation and defect repair in vivo10.5966/sctm.2015-0215 ↗
10. Mesenchymal stem cells for tendon healing: what is on the horizon?10.1002/term.2209 ↗
11. The use of cocultured mesenchymal stem cells with tendon-derived stem cells as a better cell source for tendon repair10.1089/ten.tea.2016.0248 ↗
12. Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice10.3402/jev.v4.26238 ↗
13. Tendon-derived stem cells (TDSCs) promote tendon repair in a rat patellar tendon window defect model10.1002/jor.21559 ↗
14. Fibrin glue mesh fixation combined with mesenchymal stem cells or exosomes modulates the inflammatory reaction in a murine model of incisional hernia10.1016/j.actbio.2018.02.014 ↗
15. Polycaprolactone electrospun mesh conjugated with an msc affinity peptide for msc homing in vivo10.1016/j.biomaterials.2012.01.033 ↗
16. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche10.1038/nm1630 ↗
17. Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity10.1016/j.cell.2017.08.035 ↗
18. Human adipose-derived stem cell conditioned media and exosomes containing MALAT1 promote human dermal fibroblast migration and ischemic wound healing10.1089/wound.2017.0775 ↗
19. Enhanced therapeutic effects of MSC-derived exosomes with an injectable hydrogel for hindlimb ischemia treatment10.1021/acsami.8b08449 ↗
20. Histone deacetylase inhibitor treated cell sheet from mouse tendon stem/progenitor cells promotes tendon repair10.1016/j.biomaterials.2018.03.043 ↗
21. Well-aligned chitosan-based ultrafine fibers committed teno-lineage differentiation of human induced pluripotent stem cells for achilles tendon regeneration10.1016/j.biomaterials.2015.02.051 ↗
22. Harnessing endogenous stem/progenitor cells for tendon regeneration10.1172/JCI81589 ↗
23. Biologics for tendon repair10.1016/j.addr.2014.11.015 ↗
24. Bone marrow-derived mesenchymal stem cells influence early tendon-healing in a rabbit achilles tendon model10.2106/JBJS.E.01396 ↗
25. Mesenchymal stem cells from a hypoxic culture improve and engraft achilles tendon repair10.1177/0363546513480786 ↗
26. Mesenchymal stem cells in tendon repair and regeneration: basic understanding and translational challenges10.1111/nyas.13262 ↗
27. Hypothalamic stem cells control ageing speed partly through exosomal miRNAs10.1038/nature23282 ↗
28. Exosomal small talk carries strong messages from muscle stem cells10.1016/j.stem.2016.12.009 ↗
29. Macrophage-derived miRNA-containing exosomes induce peritendinous fibrosis after tendon injury through the miR-21-5p/Smad7 pathway10.1016/j.omtn.2018.11.006 ↗
30. Extracellular vesicle-educated macrophages promote early achilles tendon healing10.1002/stem.2988 ↗
31. Tenocyte-derived exosomes induce the tenogenic differentiation of mesenchymal stem cells through TGF-β10.1007/s10616-018-0264-y ↗
32. Stem cell-derived extracellular vesicles attenuate the early inflammatory response after tendon injury and repair10.1002/jor.24406 ↗
33. Extracellular vesicles from bone marrow-derived multipotent mesenchymal stromal cells regulate inflammation and enhance tendon healing10.1186/s12967-019-1960-x ↗
34. Comparison of tenocytes and mesenchymal stem cells seeded on biodegradable scaffolds in a full-size tendon defect model10.1007/s10856-012-4791-3 ↗
35. Loss of tenomodulin results in reduced self-renewal and augmented senescence of tendon stem/progenitor cells10.1089/scd.2014.0314 ↗
36. Tenomodulin is essential for prevention of adipocyte accumulation and fibrovascular scar formation during early tendon healing10.1038/cddis.2017.510 ↗
37. Expression of tenocyte lineage-related factors in regenerated tissue at sites of tendon defect10.1007/s00776-014-0684-2 ↗
38. The regulation of tendon stem cell differentiation by the alignment of nanofibers10.1016/j.biomaterials.2009.11.083 ↗
39. Engineered scaffold-free tendon tissue produced by tendon-derived stem cells10.1016/j.biomaterials.2012.11.046 ↗
40. Cells and secretome–towards endogenous cell re-activation for cartilage repair10.1016/j.addr.2014.08.007 ↗
41. Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy10.1002/cbin.10378 ↗
42. PEDF-derived peptide promotes tendon regeneration through its mitogenic effect on tendon stem/progenitor cells10.1186/s13287-018-1110-z ↗
43. In vivo identity of tendon stem cells and the roles of stem cells in tendon healing10.1089/scd.2013.0073 ↗
44. Re-engineering extracellular vesicles as smart nanoscale therapeutics10.1021/acsnano.6b07607 ↗
45. Engineered exosomes as vehicles for biologically active proteins10.1016/j.ymthe.2017.03.030 ↗
46. Functional delivery of lipid-conjugated siRNA by extracellular vesicles10.1016/j.ymthe.2017.03.021 ↗
47. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy10.1016/j.biomaterials.2017.10.012 ↗
48. Resident c-kit(+) cells in the heart are not cardiac stem cells10.1038/ncomms9701 ↗
49. Reassessment of c-Kit(+) cells for cardiomyocyte contribution in adult heart10.1161/CIRCULATIONAHA.119.039909 ↗
50. Chitosan wound dressings incorporating exosomes derived from microrna-126-overexpressing synovium mesenchymal stem cells provide sustained release of exosomes and heal full-thickness skin defects in a diabetic rat model10.5966/sctm.2016-0275 ↗
51. Thermoresponsive gel embedding adipose stem cell-derived extracellular vesicles promotes esophageal fistula healing in a thermo-actuated delivery strategy10.1021/acsnano.8b00117 ↗
52. Fibrin glue as a drug delivery system10.1016/j.jconrel.2010.06.025 ↗